✦ LIBER ✦

Contemporary Management of Dyslipidemia in High-Risk Patients: Targets Still Not Met

✍ Scribed by Andrew T. Yan; Raymond T. Yan; Mary Tan; Daniel G. Hackam; Kori L. Leblanc; Heather Kertland; Jennifer L. Tsang; Shahin Jaffer; Martin L. Kates; Lawrence A. Leiter; David H. Fitchett; Anatoly Langer; Shaun G. Goodman

Book ID: 116211050
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 182 KB
Volume: 119
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2005.11.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of dyslipidemia in the high-r

Management of dyslipidemia in the high-risk patient

✍ Evan A. Stein 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Combined therapy of mixed dyslipidemia i

Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma

✍ Rosolova, Hana; Dobiasova, Milada; Soska, Vladimir; Blaha, Vladimir; Ceska, Rich 📂 Article 📅 2014 🏛 Czech Society of Cardiology 🌐 English ⚖ 348 KB

Usefulness of Statin–Ezetimibe Combinati

Usefulness of Statin–Ezetimibe Combination to Reduce the Care Gap in Dyslipidemia Management in Patients With a High Risk of Atherosclerotic Disease

✍ Hwee Teoh; Aurora A. Mendelsohn; Shaun G. Goodman; Shahin Jaffer; Richard Y.Y. C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Cross-Sectional Survey to Assess the Sta

Cross-Sectional Survey to Assess the Status of Lipid Management in High-Risk Patients With Dyslipidemia: Clinical Impact of Combination Therapy With Ezetimibe

✍ Tamio Teramoto; Atsunori Kashiwagi; Shun Ishibashi; Hiroyuki Daida 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 526 KB

389 Real-Life Implementation of a LDL-C

389 Real-Life Implementation of a LDL-C Treat-to-Target Strategy in the Management of Hyperlipidemia in High CVD Risk Patients in Québec

✍ S. Kouz; C. Constance; E. Rampakakis; E. Psaradellis; J. Sampalis; E. De Carolis 📂 Article 📅 2012 🏛 Pulsus Group Inc 🌐 English ⚖ 69 KB

[4] EZETIMIBE/SIMVASTATIN COMPARED WITH

[4] EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE DOSE OF SIMVASTATIN IN HIGH CARDIOVASCULAR RISK PATIENTS NOT AT LDL-C TARGET WITH SIMVASTATIN ALONE: THE DIALOGUE STUDY

✍ M. Averna; A. Zaninelli; C. Le Grazie; G.F. Gensini 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 109 KB